These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

347 related items for PubMed ID: 12053600

  • 1. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
    Kupczyk M, Kuna P.
    Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
    [Abstract] [Full Text] [Related]

  • 2. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
    Kupczyk M, Kuna P.
    Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
    [Abstract] [Full Text] [Related]

  • 3. Mucoactive agents for airway mucus hypersecretory diseases.
    Rogers DF.
    Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
    [Abstract] [Full Text] [Related]

  • 4. The pharmacologic approach to airway clearance: mucoactive agents.
    Rubin BK.
    Paediatr Respir Rev; 2006 Sep; 7 Suppl 1():S215-9. PubMed ID: 16798570
    [Abstract] [Full Text] [Related]

  • 5. Rationale of airway clearance.
    Clarke SW.
    Eur Respir J Suppl; 1989 Jul; 7():599s-603s. PubMed ID: 2679608
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Therapeutic possibilities in chronic non-specific respiratory tract diseases. 1. Modification of secretion, inhalation- and respiration therapy, therapy of bronchial obstruction].
    Löllgen H, Löllgen-Horres I, von Nieding G.
    Fortschr Med; 1976 Aug 26; 94(24):1276-84. PubMed ID: 786833
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Ambroxol in the 21st century: pharmacological and clinical update.
    Malerba M, Ragnoli B.
    Expert Opin Drug Metab Toxicol; 2008 Aug 26; 4(8):1119-29. PubMed ID: 18680446
    [Abstract] [Full Text] [Related]

  • 11. Mucolytics and antioxidant activity.
    Strapková A, Nosál'ová G, Franová S.
    Life Sci; 1999 Aug 26; 65(18-19):1923-5. PubMed ID: 10576438
    [Abstract] [Full Text] [Related]

  • 12. Impact of Mucolytic Agents on COPD Exacerbations: A Pair-wise and Network Meta-analysis.
    Cazzola M, Rogliani P, Calzetta L, Hanania NA, Matera MG.
    COPD; 2017 Oct 26; 14(5):552-563. PubMed ID: 28753070
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mucolytics, expectorants, and mucokinetic medications.
    Rubin BK.
    Respir Care; 2007 Jul 26; 52(7):859-65. PubMed ID: 17594730
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Inhalation therapy from the modern point of view].
    Stadeler HJ.
    Schweiz Rundsch Med Prax; 1971 Nov 26; 60(45):1509-12. PubMed ID: 4946731
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [The cleaning system of the airways: physiology, pathophysiology and effects of ambroxol].
    Wunderer H, Morgenroth K, Weis G.
    Med Monatsschr Pharm; 2009 Feb 26; 32(2):42-7. PubMed ID: 19263911
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.